Jones RDO, Petersson K, Tabatabai A, Bao L, et al. Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib Plus Osimertinib in an EGFR-Mutation Positive, MET-Amplified Non-Small Cell Lung Cancer Model. Mol Cancer Ther 2023 Mar 8:MCT-22-0193. doi: 10.1158/1535-7163.MCT-22-0193.
PMID: 36888921